Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Eller

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 30, 2003
Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNAMark S Eller, Guang-Zhi Li, Reza Firoozabadi, et al.
Journal of Skin Cancer|December 5, 2012
Germ cell proteins in melanoma: prognosis, diagnosis, treatment, and theories on expressionAshley M Rosa, Nitika Dabas, Diana M Byrnes, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 30, 2002
DNA oligonucleotide treatment corrects the age-associated decline in DNA repair capacityDavid A Goukassian, Sepideh Bagheri, Laila el-Keeb, et al.
Experimental Cell Research|May 25, 2002
Induction of apoptosis by telomere 3' overhang-specific DNAMark S Eller, Neelu Puri, Ina M Hadshiew, et al.
Journal of Skin Cancer|November 6, 2012
Diagnostic role of chromosomal instability in melanomaNitika Dabas, Diana M Byrnes, Ashley M Rosa, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 31, 2004
Telomere-based DNA damage responses: a new approach to melanomaNeelu Puri, Mark S Eller, H Randolph Byers, et al.
Journal of Dermatological Science|November 13, 2009
Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damageMargaret S Lee, Mina Yaar, Mark S Eller, et al.
Experimental Dermatology|July 11, 2007
Oligonucleotide treatment increases eumelanogenesis, hair pigmentation and melanocortin-1 receptor expression in the hair follicleRuzanna Y Atoyan, Andrey A Sharov, Mark S Eller, et al.
Experimental Dermatology|March 5, 2014
How, and from which cell sources, do nevi really develop?James M Grichnik, Andrew L Ross, Samantha L Schneider, et al.
Breast Cancer Research : BCR|January 30, 2007
Telomeric DNA induces apoptosis and senescence of human breast carcinoma cellsMina Yaar, Mark S Eller, Izabela Panova, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 30, 2003
Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNAMark S Eller, Guang-Zhi Li, Reza Firoozabadi, et al.
Journal of Skin Cancer|December 5, 2012
Germ cell proteins in melanoma: prognosis, diagnosis, treatment, and theories on expressionAshley M Rosa, Nitika Dabas, Diana M Byrnes, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 30, 2002
DNA oligonucleotide treatment corrects the age-associated decline in DNA repair capacityDavid A Goukassian, Sepideh Bagheri, Laila el-Keeb, et al.
Experimental Cell Research|May 25, 2002
Induction of apoptosis by telomere 3' overhang-specific DNAMark S Eller, Neelu Puri, Ina M Hadshiew, et al.
Journal of Skin Cancer|November 6, 2012
Diagnostic role of chromosomal instability in melanomaNitika Dabas, Diana M Byrnes, Ashley M Rosa, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 31, 2004
Telomere-based DNA damage responses: a new approach to melanomaNeelu Puri, Mark S Eller, H Randolph Byers, et al.
Journal of Dermatological Science|November 13, 2009
Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damageMargaret S Lee, Mina Yaar, Mark S Eller, et al.
Experimental Dermatology|July 11, 2007
Oligonucleotide treatment increases eumelanogenesis, hair pigmentation and melanocortin-1 receptor expression in the hair follicleRuzanna Y Atoyan, Andrey A Sharov, Mark S Eller, et al.
Experimental Dermatology|March 5, 2014
How, and from which cell sources, do nevi really develop?James M Grichnik, Andrew L Ross, Samantha L Schneider, et al.
Breast Cancer Research : BCR|January 30, 2007
Telomeric DNA induces apoptosis and senescence of human breast carcinoma cellsMina Yaar, Mark S Eller, Izabela Panova, et al.
Pageof 4